T1Type1Cure
Flat lay of medicines, syringes, and a blood glucose chart on a pink surface, representing health management.
Nataliya Vaitkevich (Pexels) / Pexels License
Causes & What We Know/July 11, 2026/3 min read

When You Take Insulin Before Eating May Affect Blood Flow in Type 1 Diabetes

A small clinical trial found that taking mealtime insulin 15 minutes before eating led to better blood sugar control and increased blood flow to the heart compared to injecting insulin after meals began.

causesautoimmunitygeneticsrisk

Key takeaways

  • Premeal insulin injection (15 minutes before eating) resulted in lower blood sugar levels after meals compared to postmeal injection in people with type 1 diabetes
  • Taking insulin before meals was associated with improved blood flow in the heart's tiny blood vessels
  • The study involved only 18 adults ages 18–35 with well-controlled type 1 diabetes and healthy body weight, so results may not apply to all people with type 1 diabetes
  • This is one small study; more research is needed to understand the long-term effects of insulin timing on heart health

What Researchers Wanted to Know

Scientists have long understood that high blood sugar after meals can stress blood vessels. In people with type 1 diabetes, the timing of mealtime insulin injection might affect how much blood sugar spikes after eating. A team of researchers wondered whether injecting insulin before a meal—rather than after—could help keep blood sugar rises lower and improve blood flow in the heart.

To test this idea, they compared two approaches in the same group of people with type 1 diabetes: taking insulin 15 minutes before eating versus 15 minutes after eating began. They measured blood sugar levels and various measures of blood vessel health, including blood flow in the heart's smallest blood vessels.

Who Participated and How the Study Worked

The study included 18 people with type 1 diabetes between ages 18 and 35, all with a healthy body weight. Each participant tried both insulin timing approaches on separate occasions in a randomized, crossover design—meaning each person served as their own comparison. A separate group of 18 people without diabetes ate the same meal without insulin, providing a reference point for normal blood sugar and vascular responses.

Researchers measured blood sugar, insulin levels, and several markers of blood vessel health both before and 2 hours after the meal. They looked specifically at blood flow in the heart's tiny vessels, blood vessel stiffness, and signs of inflammation and endothelial dysfunction (problems with the inner lining of blood vessels).

What the Results Showed

Taking insulin before the meal led to significantly lower blood sugar levels after eating compared to injecting insulin after the meal began. The study also found that blood flow in the heart's microvascular vessels increased more when insulin was given before eating.

These findings suggest that premeal insulin timing may help protect blood vessels by preventing sharp blood sugar spikes—a key concern for people with type 1 diabetes, since high blood sugar can damage blood vessels over time.

What This Means and What Remains Unknown

This small study offers early evidence that the timing of mealtime insulin injections may influence both immediate blood sugar control and blood vessel health. However, important questions remain unanswered. The study involved only young adults with well-controlled diabetes and healthy body weight, so findings may not apply to children, older adults, or people with different health profiles.

A single study with 18 participants cannot establish whether changing insulin timing would benefit all people with type 1 diabetes or whether the improvements in blood flow would meaningfully reduce heart disease risk over time. Larger, longer studies are needed to understand whether premeal insulin timing offers lasting cardiovascular benefits and whether it remains practical and effective across different populations and daily routines.

Evidence label

Source: Diabetologia. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.